Caris Life Sciences Showcases Data Demonstrating the Clinical Value of Clonal Hematopoiesis Identification and Subtraction in Liquid Biopsy to Improve the Accuracy of Treatment Recommendations

Posted on by

Caris Assure™ detected clonal hematopoiesis (CH) mutations in ~40% of cases and demonstrated that CH identification and correction is vital for accurate therapy selection for cancer patients IRVING, Texas, Nov. 25, 2024 /PRNewswire/ — Caris Life Sciences® (Caris), a leading…

Posted in UncategorizedTagged
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.